Skip to main content

STAAR Surgical Company (STAA)

NASDAQ: STAA · IEX Real-Time Price · USD
122.48 -3.67 (-2.91%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap5.81B
Revenue (ttm)206.20M
Net Income (ttm)20.78M
Shares Out47.10M
EPS (ttm)0.41
PE Ratio300.20
Forward PE129.87
Dividendn/a
Ex-Dividend Daten/a
Volume187,383
Open126.05
Previous Close126.15
Day's Range121.22 - 127.74
52-Week Range66.81 - 163.08
Beta1.07
AnalystsBuy
Price Target147.00 (+20.0%)
Est. Earnings DateNov 3, 2021

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the comp...

IndustryHealth Care Equipment & Supplies
Founded1982
CEOCaren Mason
Employees575
Stock ExchangeNASDAQ
Ticker SymbolSTAA
Full Company Profile

Financial Performance

In 2020, STAAR Surgical's revenue was $163.46 million, an increase of 8.84% compared to the previous year's $150.19 million. Earnings were $5.91 million, a decrease of -57.91%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for STAAR Surgical stock is "Buy." The 12-month stock price forecast is 147.00, which is an increase of 20.02% from the latest price.

Price Target
$147.00
(20.02% upside)
Analyst Consensus: Buy

News

STAAR Surgical (STAA) Sees Hammer Chart Pattern: Time to Buy?

STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon.

1 day ago - Zacks Investment Research

STAAR Surgical to Report Third Quarter Results on November 3, 2021

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

2 days ago - Business Wire

Down More Than 18% in 3 Months, Is STAAR Surgical Still A Buy?

Its valuation might be a sticking point.

1 week ago - The Motley Fool

New Strong Buy Stocks for October 7th

JBL, ING, TILE, REI, and STAA have been added to the Zacks Rank #1 (Strong Buy) List on October 7, 2021.

Other symbols:INGJBLREITILE
2 weeks ago - Zacks Investment Research

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.

Other symbols:IDXXOMCLVREX
1 month ago - Zacks Investment Research

Why Staar Surgical (STAA) Might be Well Poised for a Surge

Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 months ago - Zacks Investment Research

STAAR Surgical Stock Surges 21% After Q2 Sales Beat Expectations; Uplifts FY21 Outlook

STAAR Surgical Company (NASDAQ: STAA) Q2 sales increased 77% Y/Y to $62.4 million and up 23% on a sequential basis, beating the consensus of $52.56 million. The growth was attributable to global ICL sal...

2 months ago - Benzinga

Staar Surgical (STAA) Tops Q2 Earnings and Revenue Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 237.50% and 17.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today report...

2 months ago - Business Wire

Staar Surgical (STAA) Earnings Expected to Grow: Should You Buy?

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

3 Value Stocks That Won't Stop Growing

Their business models are timeless, and their revenue is rising.

Other symbols:ALGNRVP
2 months ago - The Motley Fool

STAAR Surgical (STAA) Sees Hammer Chart Pattern: Time to Buy?

STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon.

3 months ago - Zacks Investment Research

STAAR Surgical to Report Second Quarter Results on August 4, 2021

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

3 months ago - Business Wire

What Makes Staar Surgical (STAA) a Strong Momentum Stock: Buy Now?

Does Staar Surgical (STAA) have what it takes to be a top stock pick for momentum investors? Let's find out.

3 months ago - Zacks Investment Research

Is It Too Late to Buy Staar Surgical Stock?

This company's eye-opening surge has people wondering if it's too late to get in on the boom.

4 months ago - The Motley Fool

Why 4 Jefferies Franchise List Stocks Could Be Big Second-Half Winners

It is hard to believe, but in just over two weeks the second quarter will come to a close and many investors will be reviewing their portfolios and making changes for the second half of 2021.

Other symbols:BIOCVSGILD
4 months ago - 24/7 Wall Street

Is STAAR Surgical a Warren Buffett Stock?

He'd appreciate its margins and its moat.

4 months ago - The Motley Fool

Staar Surgical (STAA) Q1 Earnings and Revenues Beat Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 900.00% and 16.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today report...

5 months ago - Business Wire

Earnings Preview: Staar Surgical (STAA) Q1 Earnings Expected to Decline

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Why STAAR Surgical Is the Best Healthcare Stock You'll Find Today

If you wear contact lenses or eyeglasses, you're in STARR's target market.

5 months ago - The Motley Fool

STAAR Surgical to Report First Quarter Results on May 5, 2021

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

6 months ago - Business Wire

Is STAAR Surgical a Buy?

Here's why it's not too late to go long on this eye surgery lens firm.

6 months ago - The Motley Fool

3 Outside-the-Box Healthcare Stocks That Could Set You Up for Life

You probably haven't heard of these companies, but they're winners.

Other symbols:ALGNMOH
6 months ago - The Motley Fool

Buy These 3 Breakout Healthcare Stocks if There's a Sell-Off or Correction

I've been waiting to buy these stocks at a better price. Now might just be the time.

Other symbols:ABMDTDOC
6 months ago - The Motley Fool